The Leading Dermatology CRO

The Leading Dermatology CRO

CU-Tech and Synteract combine strengths

We have performed, over our combined history:

  • 230+Clinical Trials
  • 30+Indications
  • 1,200Sites
  • 57,500Patients

From ensuring consistency in rating qualitative dermatologic endpoints, to moving toward patient-centric assessments via electronic devices, and ensuring GCP compliance and high quality data—these are just a few of the challenges and opportunities that dermatology clinical trials pose.

At Synteract, we address these and more on a daily basis. With the recent acquisition of dermatology specialist CRO Cu-Tech, we further strengthened our commitment to dermatology drug development, and formed the leading dermatology CRO with strong relationships to clients and investigators, and experience and knowledge across indications.

Having completed more than 230 dermatology studies, we are uniquely qualified to provide targeted guidance on developing dermatologic products and technology across psoriasis, atopic dermatitis, acne, alopecia, skin cancer, and numerous other indications, as well as skincare products.

Our dermatology knowledge is proven across more than 30 indications and includes considerable depth in these top ones: 

Synteract Dermatology Indications Chart

Our robust strategy will help you to meet stringent timelines, while addressing your clinical study objectives. Drawing on strong relationships with clients and investigators, we leverage sites we know to have managed trials well, with the ability to administer critical scale, and be high enrolling. From design of the study protocol to implementation of the trial with effective and accurate on-site monitoring, to efficient study closure and data analysis--we propose an operational strategy that maximizes processes and cost efficiencies across your program.

“Our focus on the development of novel and in-demand dermatology drugs provides our customers with dedicated research services that are unmatched in the market.”

Jack Shannon, COO of Synteract

We meet potential challenge with solutions at the ready. This means your study moves through each milestone and stays on track.

Contact Us to learn more about how we bring your dermatology clinical trials to life!

x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract Dermatology Clinical Trial Leadership

Kit AshenfelterContact us to find out more about our Dermatology expertise and experience

Kit Ashenfelter
VP Dermatology Development

Contact us to find out more about our Dermatology expertise and experience
x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required